|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash and cash equivalents | |||||||||||||||||
| Restricted cash, current | |||||||||||||||||
| Short-term investments: | |||||||||||||||||
| Accounts receivable, net | |||||||||||||||||
| Inventory | |||||||||||||||||
| Costs capitalized to obtain contracts, net | |||||||||||||||||
| Prepaid expenses and other current assets | |||||||||||||||||
| Total current assets | |||||||||||||||||
| Restricted cash, noncurrent | |||||||||||||||||
| Property and equipment, net | |||||||||||||||||
| Costs capitalized to obtain contracts, noncurrent | |||||||||||||||||
| Prepaid expenses and other assets, noncurrent | |||||||||||||||||
| Operating lease right-of-use asset | |||||||||||||||||
| Intangible assets, net | |||||||||||||||||
| Goodwill | |||||||||||||||||
| Deferred tax assets, net | |||||||||||||||||
| Total Assets | |||||||||||||||||
| Liabilities and Stockholders’ Equity | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Accounts payable | |||||||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||||||
| Escrow liability | |||||||||||||||||
| Convertible notes, current | |||||||||||||||||
| Deferred revenue, current | |||||||||||||||||
| Total current liabilities | |||||||||||||||||
| Convertible notes, net, noncurrent | |||||||||||||||||
| Derivative liability, noncurrent | |||||||||||||||||
| Deferred revenue, noncurrent | |||||||||||||||||
| Other liabilities, noncurrent | |||||||||||||||||
| Total Liabilities | |||||||||||||||||
| Stockholders’ Equity | |||||||||||||||||
| Common Stock, $0.001 par value; 500,000,000 authorized as of June 30, 2026 and December 31, 2025; 81,531,092 issued and 81,216,330 outstanding as of June 30, 2026 and 79,359,589 issued and outstanding as of December 31, 2025 | |||||||||||||||||
| Additional paid-in capital | |||||||||||||||||
| Notes due from affiliates | |||||||||||||||||
| Accumulated deficit | |||||||||||||||||
| Accumulated other comprehensive income (loss) | |||||||||||||||||
| Treasury stock, at cost; 314,762 and 0 shares as of June 30, 2026 and December 31, 2025, respectively | |||||||||||||||||
| Total stockholders’ equity | |||||||||||||||||
| Total Liabilities and Stockholders’ Equity | |||||||||||||||||
Loading...
